Michael D. Cabana, MD, MPH
Department of Pediatrics, University of Michigan Health System
Randall Brown, MD, MPH
Department of Pediatrics, University of Michigan Health System
Noreen M. Clark, PhD
Department of Health Behavior and Health Education, University of Michigan School of Public Health
Diane F. White, RRT
Department of Pediatrics, University of Michigan Health System
Juanita Lyons, PhD
Department of Pediatrics, University of Michigan Health System
Sylvia Wanner Lang, PhD
Department of Pediatrics, University of Michigan Health System
Susan L. Bratton, MD, MPH
Department of Pediatrics, University of Michigan Health System

ABSTRACT

Purpose: To enhance primary care provider participation in a multifaceted interactive asthma teaching program sponsored by managed care organizations.

Design: Case series of six MCO- sponsored continuing medical education (CME) sessions.

Methodology: MCOs were provided with a standard set of recruitment materials. The MCO disease management divisions invited pediatric primary care providers of several types to attend the asthma teaching sessions and tracked the type of contacts employed and the success rate. Participants were awarded CME and were provided with a meal to encourage attendance. The faculty included a local physician-leader and a regional asthma expert. The sessions were scheduled by the MCO, but were given by the study group using a previously developed curriculum that emphasized material endorsed by the National Heart Lung and Blood Institute. Direct costs were tracked.

Principal findings: Overall, 53 of 299 (18 percent) providers participated in the two-part asthma CME sessions. Recruitment was significantly more successful when a physician leader participated in solicitation of providers (P<.01). Successful recruitment generally necessitated two points of contact, and phone contact appeared to yield greater success than e-mail. Scheduling conflicts and inconvenient location were the most common reasons given for not attending the seminars. Ninety percent of providers who attended the first session completed the program. The average direct cost per provider was $370.

Conclusion: Even when offering primary care providers a multifaceted interactive asthma-teaching program, physician recruitment necessitates personal and multiple contacts, and careful planning in terms of seminar location, time, and content. Interactive physician education seminars necessitate a large investment of resources but may be cost-effective if care is improved.

Author correspondence:
Michael D. Cabana, MD, MPH
Division of General Pediatrics
University of Michigan Health System
6-D-19 NIB, Box 0456
300 North Ingalls Street
Ann Arbor, MI 48109-0456

This paper has undergone peer review by appropriate members of Managed Care's Editorial Advisory Board.

Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.